These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. The intravenous injection of oxidized LDL- or Apolipoprotein B100--Coupled splenocytes promotes Th1 polarization in wildtype and Apolipoprotein E--Deficient mice. Steinmetz M; Ponnuswamy P; Laurans L; Esposito B; Tedgui A; Mallat Z Biochem Biophys Res Commun; 2015 Aug; 464(1):306-11. PubMed ID: 26116775 [TBL] [Abstract][Full Text] [Related]
45. Monoclonal antibody therapy that targets phospholipid-binding protein delays lupus activity in MRL/lpr mice. Mihaylova N; Bradyanova S; Chipinski P; Chausheva S; Kyurkchiev D; Tchorbanov AI Scand J Immunol; 2020 Sep; 92(3):e12915. PubMed ID: 32533866 [TBL] [Abstract][Full Text] [Related]
46. Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr(-/-) mice. van Leuven SI; Mendez-Fernandez YV; Wilhelm AJ; Wade NS; Gabriel CL; Kastelein JJ; Stroes ES; Tak PP; Major AS Ann Rheum Dis; 2012 Mar; 71(3):408-14. PubMed ID: 21953346 [TBL] [Abstract][Full Text] [Related]
47. Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice. Yang J; Li Q; Yang X; Li M Mol Med; 2015 Apr; 21(1):364-70. PubMed ID: 25902303 [TBL] [Abstract][Full Text] [Related]
48. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus. Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011 [TBL] [Abstract][Full Text] [Related]
49. IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production. Pan Q; Xiao H; Shi L; He Y; Cai J; Wu J; Li A; Ye L; Yang C; Liu HF Front Immunol; 2020; 11():1047. PubMed ID: 32625200 [TBL] [Abstract][Full Text] [Related]
50. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice. Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843 [TBL] [Abstract][Full Text] [Related]
51. Atherogenic antiphospholipid antibodies in antiphospholipid syndrome. Kobayashi K; Lopez LR; Matsuura E Ann N Y Acad Sci; 2007 Jun; 1108():489-96. PubMed ID: 17894014 [TBL] [Abstract][Full Text] [Related]
52. Accelerated atherosclerosis is independent of feeding high fat diet in systemic lupus erythematosus-susceptible LDLr(-/-) mice. Braun Na; Wade NS; Wakeland EK; Major AS Lupus; 2008 Dec; 17(12):1070-8. PubMed ID: 19029274 [TBL] [Abstract][Full Text] [Related]
53. ApoE-/-Fas-/- C57BL/6 mice: a novel murine model simultaneously exhibits lupus nephritis, atherosclerosis, and osteopenia. Feng X; Li H; Rumbin AA; Wang X; La Cava A; Brechtelsbauer K; Castellani LW; Witztum JL; Lusis AJ; Tsao BP J Lipid Res; 2007 Apr; 48(4):794-805. PubMed ID: 17259598 [TBL] [Abstract][Full Text] [Related]
59. The centromeric region of chromosome 7 from MRL mice (Lmb3) is an epistatic modifier of Fas for autoimmune disease expression. Kong PL; Morel L; Croker BP; Craft J J Immunol; 2004 Mar; 172(5):2785-94. PubMed ID: 14978078 [TBL] [Abstract][Full Text] [Related]
60. Expression and function of Fas on cells damaged by gamma-irradiation in B6 and B6/lpr mice. Booker JK; Reap EA; Cohen PL J Immunol; 1998 Nov; 161(9):4536-41. PubMed ID: 9794379 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]